Table 1 from Preclinical Characterization and Phase I Trial Results of a Bispecific Antibody Targeting PD-L1 and 4-1BB (GEN1046) in Patients with Advanced Refractory Solid Tumors
收藏数据链接：
官方服务：
资源简介：
Characteristics of patients treated with GEN1046
创建时间：
2022-05-02
